| Targeting human cancer by a glycosaminoglycan binding malaria protein A Salanti, TM Clausen, MØ Agerbæk, N Al Nakouzi, M Dahlbäck, HZ Oo, ... Cancer cell 28 (4), 500-514, 2015 | 231 | 2015 |
| Cabazitaxel remains active in patients progressing after docetaxel followed by novel androgen receptor pathway targeted therapies N Al Nakouzi, S Le Moulec, L Albigès, C Wang, P Beuzeboc, ... European urology 68 (2), 228-235, 2015 | 190 | 2015 |
| Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer M Korpal, X Puyang, Z Jeremy Wu, R Seiler, C Furman, HZ Oo, M Seiler, ... Nature communications 8 (1), 103, 2017 | 129 | 2017 |
| An oncofetal glycosaminoglycan modification provides therapeutic access to cisplatin-resistant bladder cancer R Seiler, HZ Oo, D Tortora, TM Clausen, CK Wang, G Kumar, MA Pereira, ... European urology 72 (1), 142-150, 2017 | 48 | 2017 |
| Clusterin knockdown sensitizes prostate cancer cells to taxane by modulating mitosis N Al Nakouzi, CK Wang, E Beraldi, W Jager, S Ettinger, L Fazli, L Nappi, ... EMBO molecular medicine 8 (7), 761-778, 2016 | 35 | 2016 |
| Human ZBP1 induces cell death‐independent inflammatory signaling via RIPK3 and RIPK1 R Peng, CK Wang, X Wang‐Kan, M Idorn, M Kjær, FY Zhou, BK Fiil, ... EMBO reports 23 (12), e55839, 2022 | 26 | 2022 |
| Abstract C89: Galeterone suppresses castration-resistant and enzalutamide-resistant prostate cancer growth in vitro. N Al Nakouzi, C Wang, D Jacoby, ME Gleave, A Zoubeidi Molecular Cancer Therapeutics 12 (11_Supplement), C89-C89, 2013 | 12 | 2013 |
| Reformation of the chondroitin sulfate glycocalyx enables progression of AR-independent prostate cancer N Al-Nakouzi, CK Wang, HZ Oo, I Nelepcu, N Lallous, CB Spliid, ... Nature Communications 13 (1), 4760, 2022 | 7 | 2022 |
| Internalization and trafficking of CSPG-bound recombinant VAR2CSA lectins in cancer cells CK Wang, I Nelepcu, D Hui, HZ Oo, S Truong, S Zhao, Z Tahiry, ... Scientific Reports 12 (1), 3075, 2022 | 4 | 2022 |
| Author Correction: Evasion of immunosurveillance by genomic alterations of PPARγ/RXRα in bladder cancer M Korpal, X Puyang, ZJ Wu, R Seiler, C Furman, HZ Oo, M Seiler, S Irwin, ... Nature communications 10, 2019 | 2 | 2019 |
| Expression and regulation of chondroitin sulfate in prostate cancer NA Nakouzi, CK Wang, I Nelepcu, C Crouzit, N Nabavi, A Almami, HZ Oo, ... Cancer Research 78 (13_Supplement), 5229-5229, 2018 | 1 | 2018 |
| Evasion of immunosurveillance by genomic alterations of PPAR gamma/RXR alpha in bladder cancer (vol 8, 103, 2017) M Korpal, X Puyang, ZJ Wu, R Seiler, C Furman, HZ Oo, M Seiler, S Irwin, ... NATURE COMMUNICATIONS 10, 2019 | | 2019 |
| A glycan-binding malaria protein provides therapeutic access to cisplatin-resistant bladder cancer HZ OO, R Seiler, SS Lee, D Tortora, G Kumar, C Wang, TM Clausen, ... Cancer Research 76 (14_Supplement), 3798-3798, 2016 | | 2016 |
Martin GleaveProfessor of Urologic Sciences, University of British ColumbiaVerified email at ubc.ca
